Tune in to Bloomberg on Saturday, September 23rd to watch!
JUPITER, Fla., Sept. 18, 2023 /PRNewswire-PRWeb/ — Advancements with Ted Danson is excited to announce an upcoming broadcast, scheduled to air on Saturday, September 23rd at 8:00 pm ET. Check local listings for more information.
Learn about recent innovations in optimized fabrication processes as the show explores how Rozen Steelworks’ (Rozen) dedicated research and development division is working to bring significant improvements and opportunities to industrial markets. Viewers will discover how Rozen’s sustainable business model is helping to streamline operations, resulting in top-quality solutions at lower costs.
Next, hear how the use of green, efficient eco-energy HVAC-R solutions are changing the way heating and cooling systems operate and consume power. Audiences will learn how Falkonair innovates and manufactures energy-efficient software programs and algorithms to bridge the gap between environmental issues and expensive operating costs throughout the Refrigeration and HVAC industry.
With a look at the current state of drug development, spectators will see how developments in cell therapy are helping to cure certain types of blood cancers, while hearing why Chimeric Therapeutics (Chimeric) is focused on the discovery, development, and commercialization of novel cell therapies, in an effort to bringing curative outcomes to more patients with cancer.
Finally, the show will explore how Somengil designs and develops cutting-edge equipment for demanding industrial tasks, where performance is critical. Audiences will learn how MultiWasher high performance industrial washing machines are designed to optimize space for improved efficiency, providing a user-friendly solution to achieve the best results.
“This episode is sure to enlighten and entertain,” said, Chad Densen, Director of Programming for DMG Productions and the Advancements series. “We look forward to sharing this information with viewers.”
About Advancements and DMG Productions: Advancements is an information-based educational television series that explores recent developments taking place across several industries and economies. Shining a light on important issues and topics impacting society today, the series features the cutting-edge improvements, state-of-the-art technologies, and innovative solutions responsible for shaping, molding, and transforming our world.
Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming for viewers and networks.
The “Weight Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. DUBLIN, Sept. 18, 2023 /PRNewswire/ — The global weight management market has witnessed substantial growth, with a…
The new technology applies artificial intelligence (AI) and bioinformatic tools to identify environmental changes that affect the activity of individual genes in immune cells. This allows GNOMX to develop tests for current or past infections, specific pathogens, antibiotic sensitivity, time of infection, prognosis, or post-infectious conditions. New tests can be developed quickly to provide results at a central laboratory or at the point of care.
The company initially plans to create differentiated epigenetic diagnostic tests for three diseases: post-COVID immune dysregulation (long COVID), acute Lyme disease, and sepsis with rapid antibiotic sensitivity guidance. In the United States, an estimated 30 million long COVID patients and their clinicians currently have no diagnostic test or definitive diagnostic criteria for this condition and continue to struggle with time-consuming and expensive evaluations. Similarly, for individuals with Lyme disease, where current tests may miss approximately 60 percent of cases, GNOMX diagnostics could reduce complications from untreated infections and the resulting high chronic medical expenses.
Founded in October 2022, GNOMX develops tests for infectious diseases and related conditions to improve health outcomes and reduce medical costs. GNOMX is led by J. Mark Junewicz, Chief Executive Officer, a 40-year veteran investment banker in life sciences and Entrepreneur-in-Residence with Mount Sinai Innovation Partners (MSIP), the commercialization arm of the Mount Sinai Health System. GNOMX’s scientific founder and Chief Scientific Officer is Stuart Sealfon, MD, Sarah B. and Seth M. Glickenhaus Professor and Chair Emeritus of the Department of Neurology, and Director of the Center for Translational Systems Biology, who has directed the DARPA-funded research program. The diagnostic technology in development was also selected for DARPA’s Embedded Entrepreneur Initiative, which helps accelerate the transition of transformative innovations into successful products.
“GNOMX is grateful to have the opportunity to transform infectious disease assessment, diagnosis, and treatment using this disruptive epigenetic diagnostic technology developed by the Mount Sinai Health System-led DARPA-project consortium,” Mr. Junewicz says. “GNOMX starts with an enormous foundation of research supported by a significant DARPA contract. Our advanced AI analytics capabilities and epigenetics focus, leading to more accurate and reliable infectious disease diagnostics, set GNOMX apart. Our tests will provide more accurate and specific information to better guide treatment and to lower health care costs.”
“We look forward to collaborating with GNOMX on the next stage of development for this potentially transformative technology and to the ultimate launch of clinical epigenetic diagnostic and prognostic tests for emerging pathogens and related conditions,” said Erik Lium, PhD, the Chief Commercial innovation Officer of the Mount Sinai Health System and the President of MSIP.
The GNOMX epigenetic diagnostic platform includes technology developed by Mount Sinai faculty and was optioned by Mount Sinai to GNOMX. Mount Sinai and Mount Sinai faculty, including Dr. Sealfon, have a financial interest in this technology and in GNOMX pursuant to the Mount Sinai Intellectual Property Policy. Mount Sinai is represented on the GNOMX Board of Directors by Felipe Araujo, PhD, Managing Director of Business Development and Licensing within MSIP.
About GNOMX Corp.
GNOMX Corp. (GNOMX), based in New York City, was founded in 2022 to commercialize host response epigenetic diagnostics based on research funded by the Defense Advanced Research Projects Agency (DARPA) Epigenetic Characterization and Observation (ECHO) program contract to an academic consortium including Icahn Mount Sinai as lead, Yale School of Medicine, Princeton University, and University of Pittsburgh School of Medicine. The DARPA-sponsored research program developed patent-pending, beyond-state-of-art methods and proof-of-principle epigenetic tests that rapidly diagnose, determine time of exposure, and monitor long-term effects of infections and other exposures. In June 2023, GNOMX executed an option with Mount Sinai for a worldwide license to this disruptive technology which provides high-specificity, low cross-reactivity, and compatibility with rapid diagnostic assays that are highly advantageous compared to any existing diagnostic or prognostic technology.
About the Icahn School of Medicine at Mount Sinai
The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to a large and diverse patient population.
Ranked 14th nationwide in National Institutes of Health (“NIH”) funding and among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges, Icahn Mount Sinai has a talented, productive, and successful faculty. More than 3,000 full-time scientists, educators and clinicians work within and across 34 academic departments and 35 multidisciplinary institutes, a structure that facilitates tremendous collaboration and synergy. Our emphasis on translational research and therapeutics is evident in such diverse areas as genomics/big data, virology, neuroscience, cardiology, geriatrics, as well as gastrointestinal and liver diseases.
Icahn Mount Sinai offers highly competitive MD, PhD, and master’s degree programs, with current enrollment of approximately 1,300 students. It has the largest graduate medical education program in the country, with more than 2,000 clinical residents and fellows training throughout the Health System. In addition, more than 550 postdoctoral research fellows are in training within the Health System.
The Icahn School of Medicine at Mount Sinai is located in New York City on the border between the Upper East Side and East Harlem and classroom teaching takes place on a campus facing Central Park. Icahn Mount Sinai’s location offers many opportunities to interact with and care for diverse communities. Learning extends well beyond the borders of our physical campus, to the eight hospitals of the Mount Sinai Health System, our academic affiliates, and globally. ——————————————————-
Mount Sinai Health System Member Hospitals: The Mount Sinai Hospital; Mount Sinai Queens; Mount Sinai Beth Israel; Mount Sinai West (previously known as Mount Sinai Roosevelt); Mount Sinai Morningside (previously known as Mount Sinai St. Luke’s); Mount Sinai Brooklyn; New York Eye and Ear Infirmary of Mount Sinai; and Mount Sinai South Nassau (previously known as South Nassau Communities Hospital).
About Mount Sinai Innovation Partners
Mount Sinai Innovation Partners (MSIP) is responsible for advancing the real-world application and commercialization of Mount Sinai discoveries and inventions, and the development of research partnerships with industry. Our aim is to translate discoveries and inventions into healthcare products and services that benefit patients and society. MSIP is accountable for the full spectrum of commercialization activities required to bring Mount Sinai inventions to life. These activities include evaluating, patenting, marketing, and licensing new technologies, building research collaborations and partnerships, coaching innovators to advance commercially relevant translational discoveries, and fostering an ecosystem of entrepreneurship within Mount Sinai and beyond. For more information, please visit https://ip.mountsinai.org.
Dr. Anil Shah’s Five Layer Neck approach was recently featured in ‘Facial Plastic Surgery & Aesthetic Medicine’. In this publication, Dr. Anil Shah describes how he takes the deeper muscles of the neck to make the neck look more aesthetically pleasing.
“Most neck liposuction procedures don’t truly lift the neck,” Dr. Shah stated. “It’s the floor of the mouth that falls with age or is genetically lower. With my technique, I am able to reposition the deeper tissues and allow for more consistently appealing outcomes.”
As we age, the floor of the mouth, which includes the base of the tongue, descends and can create a heavier appearance of the neck. This paper describes how the digastric muscle, a deep neck muscle, can be manipulated to create a longer and more lifted neck. These changes were objectively measured using a scientific method that measures how long and low your neck is.
“The hope is to remove the hype of some procedures and use validated scientific methods to analyze the neck and help patients achieve consistency with neck lifts and facelifts,” states Dr. Shah.
For more information on this publication or the Five Layer Neck approach, please contact:
Shah Aesthetics, 200 West Superior Street, Suite 200, Chicago, IL 60654 312-944-0117
Dr. Anil Shah is a board certified facial plastic surgeon who specializes in all things face and is Co-Founder of Aesthetic Skin Chicago where anything from head to toe can be changed non-surgically. Dr. Shah is an author of Nosecentric and has published over 50 scientific articles in facial plastic surgery. He has been featured in Elle, WGN, Fox and other media outlets for his expertise. He is known for his 5D rhinoplasty where he performs a nasal reshaping without a hammer and chisel. He is also known for his 5 layer neck, a comprehensive solution that addresses all layers of the neck. His innovative medical spa features such innovative treatments as all inclusive lasers (lasers that treat all skin types), male enhancement to literally make men superstars, female rejuvenation, and the latest in skin care treatments.
Assisting Hands Home Care opened a new location to serve The Villages, Florida area with professional home care services.
THE VILLAGES, Fla., Sept. 18, 2023 /PRNewswire-PRWeb/ — Assisting Hands Home Care opened their newest location in The Villages, Florida. The new office is located at 8564 Co Rd 466 #205, The Villages, FL. The Assisting Hands The Villages team will be under the management of Adam Skolnik and Linda Slonik. Inspired by their personal journey, Adam and Linda decided to open Assisting Hands Home Care in memory of their mom, Naomi, with the vision to improve the experience of the elderly, the caregivers, and their families. They are dedicated to providing quality home care services and continuing education for their caregiving team.
The Need for Home Care
By 2024, an estimated 23.54% of residents in The Villages and the surrounding areas will be over the age of 65, a 12% increase in just a little over a decade. Many live well into their 80’s, 90’s and 100’s, requiring assistance with chronic conditions such as arthritis, dementia, and loss of mobility. Over 90% of older adults prefer to age in place, making in-home care services one of the most in-demand services in our nation.
“We want to give people with a passion to help an avenue to make a positive difference in someone else’s life. Caregivers who work with the elderly, and disabled, or offer respite care for families, work diligently to take care of their clients. As experienced local business owners and caregivers, we offer our employees hands-on training, competitive pay, and flexible schedules to maintain work/life balance. We strive for all clients, and caregivers, to always be treated with respect, kindness, and dignity.”
–Adam and Linda Skolnik
About Assisting Hands Home Care
Assisting Hands Home Care provides quality home care services to assist senior citizens and people with disabilities throughout The Villages, Lady Lake, Oxford, Wildwood, Leesburg, Ocala, FL, and the surrounding areas. The mission of Assisting Hands is to help seniors to age comfortably and independently in their own homes through caregiving services.
Their caregivers are highly trained and carefully screened to ensure they have the skills and compassionate approach to provide effective care. Their elderly care services include Alzheimer’s Care, post-operative care, post-surgery recovery assistance, and non-medical home health care.
Smileyscope, a pioneering leader in medical virtual reality, is set to be showcased at the prestigious 2023 Oracle CloudWorld event in Las Vegas from September 18th – 21st.
LAS VEGAS, Sept. 18, 2023 /PRNewswire-PRWeb/ — Smileyscope, a pioneering leader in medical virtual reality, is set to be showcased at the prestigious 2023 Oracle CloudWorld event in Las Vegas from September 18th – 21st.
Attracting over 40,000 visitors, Oracle CloudWorld is one of the leading tech conferences globally. Attendees are invited to explore the CloudWorld Hub, an immersive experience where they can connect, learn, and discover the latest advancements in technology. Smileyscope will be featured in the Customer Success Zone where winners of the Bear Institute PACK (Pediatric Accelerator Challenge for Kids) are highlighted.
The Bear Institute PACK start-up competition, now in its third year, was established to address the gap in digital health innovations for children. Smileyscope’s innovative approach to drug-free pain and anxiety reduction during common medical procedures, such as IV starts and blood draws, earned it recognition as a Bear Institute PACK winner in 2021.
Smileyscope’s feature at the CloudWorld Hub will include an interactive display. Attendees are invited to experience Smileysope’s immersive virtual reality technology firsthand and understand how VR can transform healthcare experiences for patients and hospital staff alike. Rigorously tested in the world’s largest clinical trials on VR, Smileyscope has been scientifically proven to reduce pain levels by 60% and alleviate anxiety by 40%.1
“We are immensely honored to be invited by Oracle and the Bear Institute to participate in CloudWorld,” Dr. Evelyn Chan, CEO of Smileyscope, said in a statement. “This invitation not only acknowledges the success of Smileyscope but also underscores the profound ability of novel technologies to revolutionize clinical outcomes and enhance the well-being of both patients and healthcare providers. We are thrilled to be pioneering the integration of VR into medicine, reimagining healthcare for the better.”
Smileyscope is a multi-award winning digital therapeutics company with proprietary technology that reframes medical procedures using choreographed virtual-reality (VR) experiences to help reduce patient pain and anxiety, and improve the overall patient experience. Smileyscope VR is the first regulatory body approved VR product for medical procedures and is clinically proven to reduce patient pain, anxiety and the need for restraints. The device is utilized by clinicians across a range of medical procedures such as vaccines, bloodwork, wound dressings, anesthetic inductions, nitrous oxide, and plaster cast applications/removals. Smileyscope VR has partnered with over 50 US hospitals to implement the VR technology.
About Oracle:
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. As the world’s largest provider of Electonic Health Record (EHR) management, Oracle Health brings data together to enable clinicians, patients, and researchers to take meaningful action, advance health, and improve outcomes worldwide. For more information about Oracle, please visit www.oracle.com.
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company–ushering in the new era of cloud computing.
Female founder Whitney Baker lights women up with a new sense of possibility CHICAGO, Sept. 18, 2023 /PRNewswire/ — Electric Ideas, the podcast hosted by female founder and meditation teacher, Whitney Baker, is celebrating its 75th episode. Electric Ideas continues to be a beacon of…
WASHINGTON, Sept. 18, 2023 /PRNewswire/ — The American Association of Orthopaedic Surgeons (AAOS) issued formal comments to the Centers for Medicare & Medicaid Services (CMS) on the agency’s proposed payment policy changes in the Medicare program for Calendar Year (CY) 2024. In both…
“This certification is a testament to Alkuhme’s investment in and commitment to enhancing the quality of service we provide for our clients. The general public is shifting their spending toward natural, green products. Having these types of products produced in a Certified facility is the next step for all brands looking to the future as these regulations become adopted worldwide,” said Steve Berry, Alkuhme’s Chief Alchemist.
The NSF/ANSI 455 GMP standards are designed to strengthen safety, quality and trust throughout the supply chain, combine regulatory requirements with retailer quality requirements and reduce the number of audits and financial costs associated with audits. Utilizing GMP guidelines assists companies in developing and maintaining proper controls in their manufacturing process so that products are processed, manufactured and labeled in a consistent manner, and meet quality standards.
“The NSF/ANSI 455 GMP mark indicates that an NSF auditor has audited a facility, checked documents and deemed the facility compliant with GMP regulations for production,” said David Trosin, Managing Director, Global Health Sciences Certification at NSF. “We’re very pleased to grant NSF/ANSI 455 GMP certification to Alkuhme’s manufacturing facility.”
As a proud sponsor of Mother Earth, Alkuhme is committed to developing and manufacturing green and natural products. Alkuhme’s carefully crafted laundry and household cleaning products, pet care, baby care, and personal care have all been developed with clean chemistry from natural ingredients. Whether you’re looking to private label or contract package, Alkuhme’s market knowledge and natural formulation expertise can help you reach target demographics, meet business goals, and maintain your facility—without the toxins.
Alkuhme’s core values and eco-friendly philosophy drive our everyday manufacturing and packaging operations. Alkuhme is committed to upholding our social, ethical, economic, and environmental responsibilities.
About NSF
NSF is an independent, global organization that facilitates standards development to minimize adverse health effects and protect the environment. With operations in 180 countries, NSF tests and certifies products for the food, water, health sciences, and consumer goods industries. Founded in 1944, NSF is committed to protecting human health and safety worldwide. NSF is a Pan American Health Organization and a World Health Organization Collaborating Centre on Water Quality, Food Safety, and Medical Device Safety.
All are welcome to visit the new addiction medicine clinic, pick up information and meet staff on Friday, September 29, between 3 p.m. and 6 p.m.
CUMBERLAND, Md., Sept. 18, 2023 /PRNewswire-PRWeb/ — Ideal Option, a national leader in outpatient medication-assisted treatment for opioids, methamphetamine, alcohol and polysubstance, is co-hosting an open house with Maryland Wellness at their shared facility in Cumberland. The event will take place on Friday, September 29, and will kick-off with a ribbon-cutting ceremony hosted by the Allegany County Chamber at 3 p.m.
As fentanyl overdoses continue to dominate the headlines in Maryland and polysubstance use becomes more widespread, Ideal Option hopes to educate the community about the effectiveness of evidence-based medication-assisted treatment for people addicted to illicit street drugs.
According to data from the Maryland Health Department, there were more than 2,600 fatal overdoses across Maryland for the past 12 months ending April 2022, with the vast majority involving fentanyl. In 2020, more than 90% of cocaine-related deaths in Maryland occurred in combination with fentanyl.
Polysubstance use disorder is now the most common diagnosis at Ideal Option. Outcomes data from 2022 show over half of all Maryland patients tested positive for two or more substances at enrollment, and 22% tested positive for three or more substances.
On Friday, September 29, from 3 p.m. to 6 p.m., all members of the community are invited to attend the open house located at 519 N Mechanic St. Attendees will have the opportunity to explore the facility, meet the knowledgeable teams from Ideal Option and Maryland Wellness, gain insight into the services available, and engage in constructive discussions about the illicit street drug epidemic.
Throughout the open house, guests will have the chance to network, enjoy refreshments, and pick up educational materials.
For questions about this event, email Marketing Director Olivia Roe at [email protected].
About Ideal Option
Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 70,000 patients through a network of over 90 office-based medication-assisted treatment (MAT) clinics across 11 states. With a mission to serve under-served communities, Ideal Option accepts most forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available.
Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.
In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.
